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Abstract
Background: The sequestration of Muscleblind splicing regulators results in myotonic dystrophy. Previous work on
Muscleblind has largely focused on its roles in muscle development and maintenance due to the skeletal and
cardiac muscle degeneration phenotype observed in individuals with the disorder. However, a number of reported
nervous system defects suggest that Muscleblind proteins function in other tissues as well.
Results: We have identified a mutation in the Caenorhabditis elegans homolog of Muscleblind, mbl-1, that is
required for proper formation of neuromuscular junction (NMJ) synapses. mbl-1 mutants exhibit selective loss of
the most distal NMJ synapses in a C. elegans motorneuron, DA9, visualized using the vesicle-associated protein
RAB-3, as well as the active zone proteins SYD-2/liprin-a and UNC-10/Rim. The proximal NMJs appear to have
normal pre- and postsynaptic specializations. Surprisingly, expressing a mbl-1 transgene in the presynaptic neuron
is sufficient to rescue the synaptic defect, while muscle expression has no effect. Consistent with this result, mbl-1
is also expressed in neurons.
Conclusions: Based on these results, we conclude that in addition to its functions in muscle, the Muscleblind
splice regulators also function in neurons to regulate synapse formation.
Background
Myotonic dystrophy type 1 (DM1) is a disorder charac-
terized by progressive muscle degeneration and myoto-
nia, or the failure of muscles to relax. The underlying
molecular cause of DM1 is an expansion of CTG-
repeats in the 3’ untranslated region of the gene DMPK
(dystrophia myotonica-protein kinase) [1]. These
expanded CUG-repeats bind with high affinity to the
Muscleblind-like (MBNL) alternative splicing regulators
and result in the sequestration of MBNL proteins in the
nucleus [2,3], rendering them unable to perform their
normal splicing functions and disease phenotypes are
due partly to changes in splicing of MBNL target genes
(reviewed in [4]).
All metazoans have at least one MBNL-type splicing
regulator, each with two or four zinc-finger CCCH RNA-
binding domains in the amino-terminal half of the pro-
tein [5]. In crystal structures, the zinc fingers bind to
specific RNA sequences and it is hypothesized that
MBNL proteins regulate splicing by binding directly to
RNA [6].
Because MBNL proteins are enriched in muscle tissue
and skeletal and cardiac muscle defects are prominent
features of DM1, most studies of MBNL genes have
focused on their roles in muscle development and main-
tenance. Previous work demonstrated that MBNL pro-
teins are responsible for the proper splicing of the
muscle-specific chloride channel (Clcn1) and mis-spli-
cing of this gene is responsible for the muscle myotonia
observed in individuals with DM1 [7].
Muscle defects are also observed in other organisms
lacking MBNL genes. In the absence of Mbnl1 or
Mbnl2, mice exhibit both muscle abnormalities and
myotonia [8,9]. Loss of Drosophila Muscleblind is lethal
at the larval stage due to ultrastructural muscle defects
[10] and RNA interference against the Caenorhabditis
elegans MBNL homolog mbl-1 resulted in muscle disor-
ganization defects [11]. Microarray studies have revealed * Correspondence: kangshen@stanford.edu
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spliced in the absence of mouse Mbnl1 [12].
Historically, MBNL studies have focused on the role
of MBNL in muscle; however, several studies have
hinted that MBNL may also function in the nervous sys-
tem. MBNL expression has been observed in human and
mouse brain [5,13], chick photoreceptor neurons [14],
zebrafish brain and spinal cord [15], and the Drosophila
embryonic ventral nerve cord [10]. MBNL1 expression
has been observed in the cytoplasm and nuclei in
human spinal cord motorneurons [16]. Loss of Droso-
phila Muscleblind causes photoreceptor differentiation
defects [17] and humans with DM1 suffer from a range
of cognitive and behavioral deficits, including mental
retardation and behavioral disorders [18].
We identified a C. elegans mutant with a defect in
synapse formation and mapped the mutation to a locus
containing the MBNL homolog mbl-1. The nervous sys-
tem of C. elegans is composed of 302 neurons that form
approximately 5,000 synapses and 2,000 gap junctions in
a highly stereotyped and reproducible pattern [19].
Using cell-specific promoters and fluorescently tagged
synaptic vesicle-associated proteins in this well-charac-
terized system, we are able to observe synapses form in
individual neurons. In mbl-1 mutants, a subset of
synapses in the dorsal nerve cord fail to form. Interest-
ingly, we found that the neuromuscular junction (NMJ)
defect of mbl-1 can be rescued by neuronal expression,
but not by muscle expression of mbl-1, suggesting that
MBL-1 functions in neurons to regulate synapse
formation.
Results
Loss of mbl-1 alters synapse formation in the cholinergic
motorneuron DA9
Located in the preanal ganglion, the cholinergic motor-
neuron DA9 is the most posterior of the DA-type
motorneurons with a dendrite that extends anteriorly
from the cell body and an axon that extends posteriorly,
then crosses the midline of the animal via a commissure
and extends anteriorly in the dorsal nerve cord (DNC).
While in the DNC, DA9 forms approximately 25 en pas-
sant dyadic synapses onto body wall muscles and reci-
procal inhibitory VD neurons [20].
To study synapse formation in DA9, we used a cell-
specific promoter to express a green fluorescent protein
(GFP)-tagged version of the synaptic vesicle associated
protein RAB-3 (GFP::RAB-3) [21]. In wild-type animals,
RAB-3 accumulates in discrete puncta along the axon of
DA9 at stereotyped locations and co-localizes with pre-
synaptic active zone proteins. These puncta correspond
to the location of synapses in electron microscopy
reconstructions of DA9 [19,22] (Figure 1A).
While working with the strain RB771, we identified an
unmapped locus that disrupts the normal pattern of
synapses in DA9. Using SNP polymorphisms between
N2 and Hawaiian strains [23], we mapped this mutation
to the far right arm of the X chromosome. After whole
genome sequencing we identified a 70-kb deletion that
eliminates eight genes, one of which is mbl-1. Since the
wy560 mutation completely eliminates the mbl-1 locus,
it represents a null allele for this gene. A second allele,
mbl-1(tm1563), is a 513-bp deletion that eliminates all
of exon 3 of mbl-1, an exon shared among all mbl-1 iso-
forms. Exon 3 skipping is predicted to cause an in-frame
deletion of some isoforms; however, for the three iso-
forms that utilize a start codon in exon 3, the next
downstream start codon would result in a frame-shift.
Further analysis revealed that trans-heterozygous mbl-1
(tm1563)/mbl-1(wy560) a n i m a l sh a v eas y n a p s en u m b e r
phenotype identical to that of the homozygous single
mutants (Figure 2) and because the two alleles of mbl-1
showed an indistinguishable defect for DA9 synapse
number, the tm1563 allele is likely acting as a null with
respect to the DA9 synapse number phenotype.
In both mbl-1(wy560) and mbl-1(tm1563) mutant ani-
mals, several aspects of DA9 presynaptic patterning are
disrupted (Figure 1). The most penetrant phenotype is
the loss of approximately ten synapses from the DA9
synaptic region: 24.4 ± 3.6 RAB-3 puncta in wild-type
animals versus 14.3 ± 2.2 in mbl-1(wy560) mutants and
15.0 ± 2.4 in mbl-1(tm1563) mutants (standard devia-
tion, P < 0.0001, t-test; Figure 1D). To quantitatively
analyze this phenotype, we imaged the DA9 synaptic
region in ten wild-type and mutant animals by confocal
microscopy and constructed composite images of the
presynaptic regions of all ten animals by aligning them
along their anteroposterior axes (Figure 1E-G). We
observe that the most distal GFP::RAB-3 puncta are
absent in mbl-1(wy560) and mbl-1(tm1563).H o w e v e r ,
the spacing between the remaining synaptic puncta in
both mbl-1(wy560) and mbl-1(tm1563) is similar to the
spacing between GFP::RAB-3 puncta in wild-type ani-
mals. Examination of a transgenic line (wyEx1902)i n
which DA9 is labeled with a cytoplasmic fluorophore
demonstrates that DA9 neuronal morphology is normal
in mbl-1(tm1563) and loss of these distal synapses is not
a result of axonal truncation (data not shown.)
Measurement of the total fluorescence intensity of the
composite images along the x-axis demonstrates that
the peak fluorescence is indeed more posterior in mbl-1
(wy560) and mbl-1(tm1563) mutant animals compared
to wild type (Figure 1H). Furthermore, it appears that
the highest point of fluorescence intensity is lower in
mbl-1(wy560) and mbl-1(tm1563). Thus, in mbl-1
mutants, fewer synapses form and the synapses that are
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counterparts.
Imaging analysis of mbl-1(wy560) and mbl-1(tm1563)
mutants also revealed the presence of ectopic RAB-3 in
compartments of DA9 from which RAB-3 is normally
excluded. In 59% of mbl-1(wy560) and 26% of mbl-1
(tm1563) animals, we observe puncta in the DA9 den-
drite, compared to 0% for wild type (Figure 1I). When
visible, these ectopic dendritic puncta are significantly
smaller than dorsal synaptic puncta and mutants typically
h a v eo n et os i xp u n c t a .W ea l s oo b s e r v ee c t o p i cp u n c t a
in other segments of DA9, including the posterior dorsal
asynaptic region, commissure, and ventral axon.
Other pre-synaptic markers are affected in mbl-1, but
post-synaptic markers are unchanged
The RAB-3 phenotype in mbl-1 mutants prompted us to
ask whether this defect is a result of impaired synaptic
Figure 1 mbl-1 disrupts synaptic vesicle localization in the motorneuron DA9. (A-C) Localization of synaptic vesicle-associated GFP::RAB-3
in adult wild type (wyIs85) (A), mbl-1(wy560) (B) and mbl-1(tm1563) (C) mutants. Animals are oriented such that anterior is to the left and dorsal
is up. Synaptic region (square bracket), dendrite (curly bracket) and DA9 cell body (asterisk) are indicated. Scale bar represents 10 μm. (D)
Quantification of the number of axonal RAB-3 puncta observed by epifluorescence microscopy. Error bars represent standard error of the mean.
***P < 0.0001, t-test. (E-G) Confocal micrographs of ten wild-type (wyIs85), mbl-1(wy560) or mbl-1(tm1563) animals, straightened and aligned
along their anteroposterior axes. Scale bar equals 10 μm. Anterior is to the left. (H) Quantification of fluorescence intensity along the x-axis of
the composite images. Dotted lines represent actual values and solid lines represent a 10-μm sliding average of fluorescence intensity. (I)
Percentage of animals with visible puncta in the dendrite in wild-type, mbl-1(wy560) and mbl-1(tm1563) animals.
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tion by analyzing the localization of other pre-synaptic
proteins. The presynapse is a complex structure com-
posed of many active zone proteins required to facilitate
the exocytosis of synaptic vesicles in response to an
action potential, as well as vesicle-associated proteins
that allow active zone machinery to interact with synap-
tic vesicles [24]. We expressed two fluorescently tagged
a c t i v ez o n ep r o t e i n s ,U N C - 1 0( R i m )[ 2 5 ]a n dS Y D - 2
(Liprin-a) [26], in DA9 and examined their localization
in the wild-type and mbl-1(tm1563) DA9 synaptic
regions (Figure 3A). We find that UNC-10::GFP co-loca-
lizes with mCherry::RAB-3 at DA9 synapses in both
wild-type and mbl-1(tm1563) animals, though there are
fewer puncta overall in mbl-1(tm1563) mutant animals
compared to wild-type animals (Figure 3B-G). Similarly,
we find that GFP::SYD-2 and mCherry::RAB-3 co-loca-
lize, but there are again fewer total DA9 presynaptic
puncta in mbl-1(tm1563) (Figure 3H-M). Taken
together, these data suggest the defect in mbl-1(tm1563)
represents the failure of synapse formation in the most
distal part of the DA9 synaptic region.
To clarify whether the DA9 defect we observe is the
result of improper synapse maintenance during develop-
ment or an acute loss of synapses at the adult stage, we
measured the length of the DA9 synaptic region in ani-
mals at the L2, L4, and adult stages (Figure 4). We mea-
sured the synaptic length rather than counting
individual puncta because puncta are densely clustered
in young animals, making it difficult to count individual
punctum. We observe that there is a consistently shorter
synaptic region in DA9 in mbl-1(tm1563) at all time-
points measured. This absolute difference translates to a
28% decrease in synapse length at the L2 stage, a 28%
decrease at the L4 stage, and a 35% decrease in young
adults. These results demonstrate that mbl-1 mutants
animals consistently fail to accumulate the appropriate
amount of synaptic material at the DA9 synaptic region
throughout development.
We next asked whether the change in DA9 synaptic
patterning is accompanied by changes in the postsynap-
tic muscle partner as loss of MBNL in human, mouse,
and Drosophila all result in muscle changes. DA9 forms
dyadic synapses onto body wall muscles and VD inhibi-
tory motorneurons. Upon DA9 acetylcholine release,
acetylocholine binds to postsynaptic acetylcholine recep-
tors on body wall muscles and causes contraction of
dorsal body wall muscles. The C. elegans acetylcholine
receptor, ACR-16, is important for excitatory neuronal
transmission at the NMJ [27] and localizes in a discrete
line along the dorsal body wall muscles.
We examined ACR-16::GFP localization in wild-type
and mbl-1(tm1563) mutants (Figure 5A-F). ACR-16:GFP
localization was qualitatively similar between wild-type
and mutant animals, with relatively continuous staining
along the DNC. ACR-16 staining appears to cover more
area compared with the RAB-3. This is to be expected
because the ACR-16 staining represents postsynaptic
specializations with both DA and DB classes of neurons,
Figure 2 Quantification of rescue of DA9 synaptic defect. (A)
Quantification of the rescue of the DA9 synapse defect in mbl-1
(tm1563) mutants with fosmid WRM0616bE04 tagged with GFP::SL2::
mCherry (wyEx4512 and wyEx4513). Error is standard error of the
mean. **P < 0.001, ***P < 0.0001. (B) Rescue of DA9 synapse
number in mbl-1(wy560) with tagged fosmid (KAS138-5). Trans-
heterozygous mbl-1(tm1563)/mbl-1(wy560) animals have a similar
phenotype to homozygous mutants.
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Qualitative observation of mCherry::RAB-3 puncta in
both wild-type and mbl-1(tm1563) worms reveals that
most RAB-3 co-localizes with ACR-16::GFP in the DNC
(data not shown).
Previous reports have documented muscle defects in
mbl-1 mutant animals [11]. We examined muscle mor-
phology in two transgenic lines in which muscles are
labeled with a cytoplasmic fluorophore, wyEx661 [20]
and trIs30 [ 2 8 ]( F i g u r e5 G - I ) .W ef i n dt h a tb o t hd o r s a l
and lateral body wall muscle morphology is qualitatively
normal in mbl-1 mutants. Muscles in both wild type
and mutant are of similar size and shape.
In C. elegans, specialized extensions called muscle
arms extend from the muscle to reach motor axons to
form NMJs. Therefore, similar to dendritic spines, mus-
cle arms represent postsynaptic components for NMJ
formation in C. elegans. We found that muscle arms
from both the dorsal and lateral muscles in mbl-1
(tm1563) appear qualitatively normal in size and shape
(Figure 5G-J). We further quantified the number of
muscle arms from the lateral muscles and found that
the number of muscle arms per muscle for wild-type
and mbl-1(tm1563) animals are not significantly differ-
ent from each other (3.7 ± 0.5 for wild type and 3.9 ±
0.7 for mbl-1(tm1563)) (Figure 5I, J). Taken together,
these results demonstrate that the mbl-1 mutant pheno-
type does not affect muscle arm outgrowth or
postsynaptic receptor localization, and we hypothesized
that the phenotype reflects a defect in synapse formation
on the presynaptic side.
mbl-1 functions cell autonomously in DA9
To confirm that mutations in mbl-1 cause the synaptic
defects observed, we rescued the mbl-1 phenotype by
injecting a fosmid (WRM0616bE04) that contained
genomic DNA encompassing all of the mbl-1 exons and
introns as well as upstream and downstream non-coding
sequences. We found the presence of the genomic frag-
ment completely restored the wild-type number of
synapses in a mbl-1(tm1563) mutant background (25.2 ±
3.5 and 25.7 ± 3.6; Figure 6B). Rescue was determined
by counting the number of visible DA9 synaptic puncta
on an epifluorescence microscope.
To determine if the synaptic defects we observe in
mbl-1 were due to changes in the presynaptic neuron
DA9 or to changes in the postsynaptic body wall mus-
cle, we performed cell autonomous rescue experiments
(Figure 6). We expressed a genomic fragment including
most of the mbl-1 ORF under the control of promoters
that express in neurons including DA9 (Pmig-13 or
Punc-4c) or body wall muscles (Phlh-1) and scored res-
cue of the DA9 synaptic phenotype in mbl-1(tm1563)
mutant animals (Figure 6B). While expression of mbl-1
in muscle failed to rescue the DA9 synaptic defect
(wyEx4028, 16.0 ± 3.3; wyEx4046, 15.3 ± 2.8), expression
Figure 3 Localization of pre-synaptic proteins is disrupted in mbl-1 mutants. (A) Schematic of DA9 and wild-type localization of RAB-3.
(B-G) Co-localization of RAB-3 and UNC-10 in wild type (B-D) and mbl-1(tm1563) (E-G). (wyEx3709). (H-M) RAB-3 and the active zone protein
SYD-2 in wild type (H-J) and mbl-1(tm1563) (K-M). Transgene used is wyEx2055. Scale bar represents 10 μm.
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Page 5 of 14Figure 4 Measurement of synapse length. (A-D) Representative images of DA9 synapses labeled with SNB-1::YFP in animals that are
approximately 15 hours old and at the L2 stage (A, B) and approximately 40 hours old and at the L4 stage (C, D). Transgene used is wyIs92. (E-
F) Images of GFP::RAB-3 in early-stage adult animals. Trasgene used is wyIs85. (G) Quantification of synapse length at three stages for wild-type
(blue) and mbl-1(tm1563) (red) animals.
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the DA9 synaptic defect. Punc-4c, a truncated version of
the unc-4 promoter (unpublished reagent via MV and
KS), drives expression in only the DA-type motorneur-
ons. Expression of the mbl-1 genomic fragment under
the control of the unc-4c promoter rescues the DA9
synaptic defect (wyEx4025, 23.4 ± 3.8; wyEx4026,2 3 . 0±
3.7). The mig-13 promoter is expressed in DA9, VA12
and other anterior DA neurons and is expressed begin-
ning at embryonic stages. When we used Pmig-13 to
drive expression of the mbl-1 genomic fragment, we
found that it also significantly restores the correct num-
ber of synapses to the dorsal axon in DA9 (wyEx4030,
22.4 ± 4.0; wyEx4234, 21.5 ± 3.5). Thus, we conclude
that mbl-1 is required cell autonomously in the presy-
naptic neuron to regulate the number of synapses.
Expression of genomic mbl-1 in DA9 can also rescue
the appearance of ectopic d e n d r i t i cp u n c t ai nmbl-1
(tm1563). Expression of the mbl-1 genomic fragment
under the control of the Pmig-13 or Punc-4c promoters
can rescue or partially rescue the appearance of ectopic
dendritic puncta. In mbl-1(tm1563),2 6 %o fa n i m a l s
have some dendritic puncta versus 0% and 13% with the
Pmig-13 promoter, 4% and 10% with the Punc-4c pro-
moter, versus 18% and 19% with the Phlh-1 promoter.
mbl-1 is expressed in the C. elegans nervous system
In order to examine the expression pattern of mbl-1,w e
inserted an SL2::mCherry sequence into the fosmid
(WRM0616bE04) containing the mbl-1 ORF by homolo-
gous recombination. The SL2 sequence acts as a trans-
splice acceptor [29] whereby the transcript is expressed
under the control of the mbl-1 promoter and is later
spliced into two separate mRNAs that are translated
independently. The recombineered fosmid results in
expression of endogenous, untagged MBL-1 and cyto-
plasmic mCherry, both under the control of the endogen-
ous mbl-1 promoter. Examination of transgenic worms
carrying the recombineered fosmid reveals that the mbl-1
promoter drives expression of mCherry in many cell
bodies along the ventral nerve cord (Figure 6C, F). Thin
neuronal processes emanate from these cell bodies and
fasciculate in both the dorsal and ventral nerve cords.
To determine the neuronal subtypes that express
MBL-1, we co-injected the recombineered fosmid with
Punc-4::GFP, a construct that drives expression of GFP
in the A-type (DA and VA) motorneurons [30]. By
examining expression patterns of GFP and mCherry, we
find that MBL-1 is expressed strongly in all of the A-
type motorneurons, and also in other neurons in the
ventral cord and several unidentified cells in the tail.
Figure 5 Localization of post-synaptic receptor ACR-16 and
body wall muscle morphology is normal in mbl-1. (A-F)
Postsynaptic receptor ACR-16::GFP co-localizes with presynaptic
mCherry::RAB-3 in wild type (A-C) and mbl-1(tm1563) (D-F) mutants
in the dorsal nerve cord. ACR-16 is shown in green and RAB-3 is
shown in red. (G, H) Dorsal body wall muscles labeled with myr-
mCherry extend muscle arms towards the dorsal nerve cord where
DA9 synapses are labeled with SNB-1::YFP. Muscles and SNB-1 are
pseudocolored green and red, respectively. Two representative
muscle arms are indicated with a white triangle for each genotype.
(I, J) Lateral body wall muscles labeled with membrane-tethered
yellow fluorescent protein (YFP; green) extend muscle arms towards
the dorsal nerve cord labeled with mCherry (red). Four muscle arms,
each indicated by a white triangle, are observed per muscle for
both wild type and mbl-1(tm1563).
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Page 7 of 14Figure 6 MBL-1 is required cell autonomously in DA9 and is expressed in many dorsal cord neurons. (A) Genomic region of the X
chromosome including mbl-1. mbl-1(tm1563) deletion is indicated above a schematic of genomic region. All cDNA isoforms were reported by
Sasagawa et al. [31]. Bottom: schematic of genomic rescuing constructs. Black boxes represent exons and thin black lines represent introns. Thin
gray lines indicate splicing patterns. (B) Quantification of the number of DA9 synapses present in the dorsal cord. Two independent transgenic
lines were scored for each rescuing construct. Error bars represent standard error of the mean. ***P < 0.0001, t-test. (C-H) Endogenous
expression of MBL-1 (magenta) and co-localization with A-type motorneurons (green). Transgene used is wyEx4015. MBL-1 is expressed in the
posterior ventral cord neurons DA8, DA9, VA12, and VA11 (C-E). (F-H) MBL-1 is expressed in A-type motorneurons. DAs can be identified by their
commissure crossing the midline of the animals. Scale bar represents 10 μm.
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mals, indicating that mbl-1 is expressed early in devel-
opment. Our expression data are largely consistent with
previously reports using a smaller fragment of the mbl-1
promoter [31].
To determine the subcellular localization of mbl-1,w e
created a translational fusion construct by adding a GFP
to the carboxyl terminus of mbl-1.E x p r e s s i o no fM B L -
1::GFP was driven by the endogenous mbl-1 promoter
and we observed that MBL-1::GFP is concentrated in
the nucleus of ventral cord neurons, consistent with its
putative function in pre-mRNA splicing, which occurs
in the nucleus (Figure 7).
DA synapse density is altered in mbl-1
Because mbl-1 is expressed in all A-type motorneurons,
we tested whether synapse formation is defective in other
neurons of this class. Using a transgenic line that expresses
GFP::RAB-3 in all DA neurons under the control of the
unc-4 promoter, we found that DA synapse density is
decreased from 43.2 synapses per 100 μmi nw y I s 8 5t o
37.3 synapses per 100 μmi nmbl-1(tm1563) (P < 0.0001)
(Figure 8). Individual DA synaptic regions cannot be dis-
cerned in this transgenic line, but changes in synapse den-
sity arise from significantly large gaps between puncta at
regular intervals (Figure 8, arrowheads), rather than a
change in the distance between all puncta, implying that
all DA synaptic regions are shortened in a similar fashion.
Loss of mbl-1 affects backwards locomotion
To understand whether the synaptic phenotypes in the
mbl-1 mutant affect behavior, we specifically examined
the backward locomotion of mbl-1 mutants because the
A-type motor neurons are involved in backward loco-
motion [32]. We observed that as mbl-1 animals move
backwards, they do not back in a straight line as wild-
type animals do. Instead, they move backwards more
slowly and curve ventrally (Figure 9A-D).
To quantify the backwards locomotion defect, we
tapped worms on the head with a platinum wire and
recorded the angle of backwards movement where the
axis of the preceding forward movement is defined as
0°. A ventral turn during backing is recorded as a posi-
tive angle (+) and a dorsal turn as negative (-). The
average angle after moving backwards two body
lengths for wild type was 0.8 ± 1.5° and 42.0 ± 7.2° for
mbl-1(tm1563) (Figure 9E). Often the worms will curve
45° per body bend. In addition, mbl-1(tm1563) worms
often back over many more body lengths than wild-
type worms and rarely perform omega bends. This
change in backwards locomotion could be explained by
the hypocontraction of dorsal body wall muscles in
response to a decrease in the density of DA9 motor-
neuron synapses.
When the same genomic fragment that rescues the
DA9 synaptic defect (mbl-1 genomic exons 3 to 8) is
expressed under the control of the neuronal-specific
promoters Pmig-13 and Punc-4c, we find that the back-
ing behavior is partially rescued. In contrast, when mbl-
1 is expressed under the control of a muscle-specific
promoter (Phlh-1), the backing behavior is not rescued.
The angles observed after two lengths of backwards
movement were 9.0 ± 2.4° for Pmig-13, 19.8 ± 5.0° for
Punc-4c, and 41.3 ± 5.7° for Phlh-1 (Figure 9E). These
results suggest that the loss of dorsal synapses in DA9
has a measurable affect on backwards locomotion.
Discussion
In this report we present evidence that the C. elegans
MBNL splicing regulator mbl-1 plays a role in neuromus-
cular junction synapse formation. A mutation in mbl-1
causes a decrease in synaptic density in the cholinergic
DA motorneurons and a corresponding defect in the
backwards locomotion behavior that these neurons con-
trol. We also observed gaps along the dorsal cord where
bright synapses would normally be present in wild-type
animals. Using a marker that labels only the most poster-
ior DA neuron, DA9, we observed that the ten most dis-
tal synapses in DA9 do not form in mbl-1 mutant
animals. In addition, GFP::RAB-3 localizes ectopically in
the dendrite or asynaptic regions of the neuron.
Our data suggest that the defects observed in DA9 are
due to the loss of mbl-1 specifically in DA9. We
observed that mbl-1 expression in the presynaptic neu-
ron DA9 was sufficient to rescue both the DA9 synaptic
defect and a backwards locomotion defect mediated by
DA9. Although muscle defects are seen in mice or Dro-
sophila when MBNL1 or Muscleblind is absent [8,10],
we observe no change in the muscle acetylcholine recep-
tor ACR-16 localization, nor does expression of an mbl-
1 transgene in muscles rescue the DA9 synaptic defect.
Taken together, these results strongly suggest that mbl-
1 functions cell autonomously in DA9 to control aspects
of synapse formation and behavior.
The mechanism by which mbl-1 might be affecting
synapse formation is still unknown. Although C. elegans
mbl-1 itself has not been shown to be a regulator of
alternative splicing, it shares a significant amount of
homology with human, mouse, and Drosophila MBNL
sequences, binds to similar repetitive RNA sequences as
human MBNL1, and co-localizes with CUG repeat-con-
taining nuclear foci in a C. elegans model of DM1
[31,33]. If C. elegans mbl-1 is a regulator of alternative
splicing, it is likely that the defects we observe in mbl-1
mutants are due to changes in the splicing patterns of
downstream target genes. Previous studies identified a
number of mis-splicing events in MBNL loss-of-function
models. Two of these genes, tau/MAPT and the N-
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the nervous system [34]. We tested if loss of the C. ele-
gans genes ptl-1/tau or nmr-1/NMDA receptor resulted
in changes in C. elegans NMJ synapse formation. We
found that there are no defects in synapse formation in
these mutants and the results suggest that the defects
we observe in mbl-1 are not due to changes in expres-
sion levels of these genes.
There are several possible cell functions that are
affected downstream of mbl-1 and lead to the observed
DA phenotype. The loss of the most distal synapses in
the DA9 synaptic region and the resulting gaps visible
along the dorsal cord could be a result of an alteration
in intracellular trafficking dynamics such that the most
distal synapses never received a sufficient supply of
synaptic vesicle precursor vesicles to build a synapse.
Figure 7 MBL-1::GFP localizes to the neuronal nucleus. (A, B) A genomic construct expressing MBL-1::GFP (green) (A) and cytoplasmic
mCherry (magenta) (B) under the control of the endogenous mbl-1 promoter. (C) Merged image of (A) and (B). MBL-1::GFP is concentrated in
the nucleus (dashed line) of the cell body (solid line). Scale bar represents 10 μm.
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sors can have dramatic effects on synapse formation. Loss
of the Drosophila Kinesin-3 imac leaves motorneuron axon
guidance and morphology unchanged, but causes a dra-
matic reduction of active zone protein accumulation at
presynaptic sites [35]. Mutations in the cargo-binding plex-
strin-homology (PH) domain of the C. elegans KIF1A
homolog unc-104 affects both transport of synaptic vesicles
to the synapse and motor velocity [36,37]. The defect we
observe in mbl-1 could be caused by a small change in
motor activity, which reduces cargo-binding capacity or
decreases motor velocity, and thus the efficiency of
transport.
We know of several extrinsic cues that are required to
specify the DA synaptic regions. The posterior border of
the DA9 synaptic region is established via a gradient of
the secreted Wnt protein lin-44 and its receptor Frizzled
(lin-17), expressed in DA9 [20]. Our lab has also identi-
fied binding between plexins and semaphorins as
essential to establishing the synaptic domains for each of
the DA neurons, a process referred to as ‘tiling’ (KM and
KS, unpublished data). Mutations in the plexin plx-1 and
the semaphorin smp-1 lead to overlap between individual
DA synaptic regions, though the mechanism by which
they function is unknown. In mbl-1 we observe gaps,
rather than overlaps, between individual DA neurons, but
it is possible that mbl-1 regulates some aspect of the til-
ing process and effectively shortens synaptic domains.
Materials and methods
Strains and genetics
The wild-type reference was the N2 Bristol strain.
Strains were maintained by standard methods [38]. mbl-
1(wy560) was originally obtained from the Deletion
Consortium as strain RB771. The hum-4(ok550) deletion
mutation was outcrossed away from the mbl-1(wy560)
allele and the resulting strain is TV7337. mbl-1(tm1563)
was obtained from the Mitani lab.
Figure 8 mbl-1 reduces DA synapse density. (A, B) GFP::RAB-3 expressed in all DA neurons (wyIs222) in wild type (A) and mbl-1(tm1563) (B).
Gaps in mbl-1(tm1563) are indicated with arrowheads. Image is of the dorsal nerve cord and anterior is to the left. Scale bar represents 10 μm.
(C) Synapse density difference per 100 μm in wyIs85 and mbl-1(tm1563). Error respresents standard error of the mean. ***P < 0.001, t-test.
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Page 11 of 14Figure 9 Locomotion is altered in mbl-1 mutants.( A ,B )Cartoon of typical backwards locomotion stimulated by tapping the head for wild
type (A) and mbl-1(tm1563) (B). The thick gray line and gray arrow indicate tracks and direction of forward movement. The solid black line
represents backwards movement. In the diagram, anterior is to the left and dorsal is up. A red triangle on the circular diagram indicates the final
angle that would be recorded in this example of the backwards locomotion assay. (C, D) Frames from movies of backwards locomotion where
the stimulus is delivered at t = 0 s (C’,D ’). Both (C, D) are at -2 s. (C”,D ’’) Images of the final worm position before re-starting forwards
locomotion (C’’, t = 2 s; D’’, t = 6.3 s). (E) Quantification of the angle of backwards locomotion for wild type, mbl-1(tm1563) and transgenic
strains where mbl-1 is expressed under the control of neuronal- or muscle-specific promoters. A positive angle represents a ventral preference
during backing. Error bars represent standard error of the mean. ***P < 0.0001, t-test.
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The following plasmids and transgenic strains were gener-
ated using standard techniques: wyIs85 (Pitr-1 pB::GFP::
rab-3), wyIs92 (Pmig-13::snb-1::YFP), wyIs222 (Punc-4::
GFP::rab-3), wyEx661 (pRF4(rol-6(su1006)), Pmyo-3::myr::
mCherry, Pmig-13::SNB-1::YFP), wyEx802 (pRF4(rol-6
(su1006)), Pmyo-3::acr-16::GFP, Pmig-13::mCherry::rab-3),
wyEx1902(Pitr-1pB::mCherry), wyEx2055 (Pitr-1::GFP::syd-
2, Pitr-1::mCherry::rab-3), wyEx3709 (Pmig-13::unc-10::
GFP, Pmig-13::mCherry::rab-3), wyEx4015 (WRM0616bE
04::SL2::mCherry, Punc-4::GFP), wyEx4029 (WRM0616bE
04 injected at 5 ng/μl), trIs30 (Phim-4p::MB::YFP, Phmr-
1b::DsRed2, Punc-129nsp::DsRed2). Rescue of mbl-1
(wy560) by Pmig-13::mbl-1 genomic exons 3-8 involved
injection of plasmid KAS138 into the mutant animals at
10 ng/μl. The co-injection markers Podr-1::GFP and Podr-
1::dsRED (20 ng/μl) were used for most strains. wyEx661
and wyEx802 used pRF4(rol-6(su1006))a t5 0n g / μl.
Rescuing constructs were constructed by using the
primers 5’-CAAGGGGGCGCGCCATGTTCGACGAA-
AACAGTAATGCCG-3’ and 5’-GGTACCCTAGAAT-
GGTGGTGGCTGCATGTA-3’ t oa m p l i f ya6 . 6 - k b
fragment called ‘mbl-1 genomic exons 3-8’.T h i sf r a g -
ment was inserted into a plasmid carrying the appropri-
ate promoter using AscI and KpnI restriction sites.
Strains constructed were the following: wyEx4030 and
wyEx4234 (Pmig-13::mbl-1 genomic exons 3-8),
wyEx4025 and wyEx4026 (Punc-4c::mbl-1 genomic exons
3-8), wyEx4028 and wyEx4046 (Phlh-1::mbl-1 genomic
exons 3-8).
Imaging
Epifluorescence imaging was conducted on a Zeiss
AxioSkop or AxioVivison epifluorescent microscope
with a mercury or X-cite light source. To create compo-
site images of DA9 synaptic regions, ten confocal images
were obtained for each genotype using the same imaging
parameters on a Zeiss LSM 710 confocal microscope.
Images were processed in ImageJ [39] using the
Straighten.jar plugin [40]. A line was drawn from the
point at which DA9 reaches the dorsal cord to the most
anterior part of DA9 captured in the image. After isolat-
ing all of these images, we aligned them along their
anteroposterior axes and assembled them into a compo-
site image in Adobe Illustrator. Fluorescence intensities
were graphed using values generated with the ImageJ
function ‘Plot profile’.
Backwards locomotion assay
To assay backwards locomotion, worms were transferred
onto freshly spotted plates 20 to 60 minutes before the
assay. Individual worms that had just completed forward
locomotion of at least two body lengths were tapped
and the resulting backing angle was observed and
recorded. The assay was repeated three times for each
individual and an average of the three trials was taken.
Images of the assay were captured with a Q-Imaging
Retiga 2000R camera mounted on a Zeiss Stemi SV11
dissection microscope.
Identification of the wy560 deletion
We performed snip-SNP mapping using SNPs from the
Hawaiian strain [23] to identify a 1.5-Mb region on the
extreme right end of the X chromosome containing the
mutant allele. Deep sequencing on a Solexa Illumina
sequencer revealed that the wy560 deletion spans from
16,983,396 to 17,048,700 on the X chromosome. This
65-kb deletion eliminates eight genes. Only the fosmid
WRM0616bE04 rescued the DA9 synaptic phenotype.
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